Alzheimer\'s disease related peptides affected cholinergic receptor mediated poly(ADP-ribose) polymerase activity in the hippocampus

Journal Title: Folia Neuropathologica - Year 2005, Vol 43, Issue 3

Abstract

Our previous studies indicated that Alzheimer's disease (AD) related amyloid beta peptide (Aβ) significantly altered muscarinic cholinergic receptor (mChR) signaling on the level of G protein regulated phospholipase C (PLC) leading to the lower formation of inositol-1,4,5-triphosphate (IP3) and diacylglycerol (DAG). Recent studies indicated that poly (ADP-ribose) polymerase-1 (PARP-1) is a new nuclear target in signal transduction pathway in the brain. In this study the effect of Aβ 25-35 (25 µM) and non-Aβ component of Alzheimer's disease amyloid (NAC, 10 µM) on mChR-dependent signaling to PARP-1 was determined. PARP-1 activity was estimated radiochemically using egzogenous substrate adenine[14C]NAD. The results showed that the non hydrolysable agonist of mChR, carbachol (1 mM) together with GTP(g)S (100 µM) stimulated PARP-1 activity in the hippocampus by about 100%. TMB-8, inhibitor of IP3 receptor decreased PARP-1 activation evoked by carbachol/GTP(g)S. Stimulation of mChR did not lead to free radicals generation but activate PARP-1 through IP3/Ca2+ regulated processes. This cholinergic receptor dependent PARP-1 activation was abolished by Aβ and NAC peptide. These toxic peptides themselves significantly stimulated PARP-1 activity by free radicals mediated DNA damage. These data indicated that Aβ and NAC peptide affected mChR-dependent signal transduction to PARP-1 probably through free radicals evoked inhibition of IP3 formation by phospholipase C.

Authors and Affiliations

Agata Adamczyk, Henryk Jęśko, Robert Strosznajder

Keywords

Related Articles

Inhibition of poly(ADP-ribose) polymerase activity protects hippocampal cells against morphological and ultrastructural alteration evoked by ischemia-reperfusion injury

Poly(ADP-ribose) polymerase 1 (PARP-1 EC 2.4.2.30) is a nuclear enzyme that plays an important role in cell survival and death. PARP is involved in DNA repair machinery, however, massive DNA damage leads to overactivatio...

CCL2 (MCP-1) and CCL5 (RANTES) levels in the peripheral blood of multiple sclerosis patients treated with Glatiramer Acetate (Copaxone)

The MCP-1 and RANTES levels were measured in 20 multiple sclerosis patients before and after 1 year daily treatment with 20 mg of subcutaneously applied glatiramer acetate. The level of MCP-1 in serum from multiple scler...

Ultrastructural study of cerebellar dentate nucleus astrocytes in chronic experimental model with valproate

The current study focuses on the morphogenesis of changes in the cerebellum dentate nucleus in the course of experimental valproate encephalopathy. Valproate – a broad spectrum antiepileptic and antipsychotic drug – chro...

Leukoencephalopathy with vanishing white matter due to homozygous EIF2B2 gene mutation. First Polish cases

Leukoencephalopathy with vanishing white matter (VWM), also called childhood ataxia with central nervous system hypomyelination (CACH), is an autosomal recessive disease caused by mutations in any of the five genes encod...

Download PDF file
  • EP ID EP133848
  • DOI -
  • Views 74
  • Downloads 0

How To Cite

Agata Adamczyk, Henryk Jęśko, Robert Strosznajder (2005). Alzheimer\'s disease related peptides affected cholinergic receptor mediated poly(ADP-ribose) polymerase activity in the hippocampus. Folia Neuropathologica, 43(3), 139-142. https://europub.co.uk./articles/-A-133848